Original Research

DOI: 10.4244/EIJ-D-25-00229

Coronary flow and resistance patterns indexed by subtended myocardial mass in coronary microvascular dysfunction

Thabo Mahendiran1,2, BMBCh, MD; Nikolaos Stalikas1, MD; Emanuele Gallinoro1,3, MD, PhD; Danielle Keulards4, MD, PhD; Koshiro Sakai1,5,6, , MD, PhD; Frederic Bouisset1, MD; Michele Mattia Viscusi1, MD; Sara Corradetti1, MD; Jeroen Sonck1, MD, PhD; Marcel van ’t Veer4,7, MS, PhD; Adriaan Wilgenhof1,8, MD; Nico H.J. Pijls4,7, MD, PhD; Carlos Collet1, MD, PhD; Bernard De Bruyne1,2, MD, PhD

Abstract

Background: Patients with coronary microvascular dysfunction (CMD) exhibit impaired vasodilatation of the microcirculation. This manifests as reduced microvascular resistance reserve (MRR) due to either increased resting flow (Qrest; functional CMD) or decreased hyperaemic flow (Qhyper; structural CMD). However, coronary flow is intimately linked to myocardial mass, potentially confounding the interpretation of flow and resistance measurements.

Aims: We investigated the relationship between subtended myocardial mass, microvascular resistance, and coronary flow to determine whether the disturbed resistance and flow patterns seen in CMD persisted after indexing by subtended myocardial mass.

Methods: We recruited 100 patients with angina with non-obstructive coronary arteries who underwent coronary computed tomography angiography to quantify vessel-specific subtended myocardial mass. Continuous intracoronary thermodilution was used to quantify absolute coronary flow and microvascular resistance, both at rest and during hyperaemia. Among patients with an MRR <3.0, hyperaemic microvascular resistance (Rμ,hyper) ≥475 Wood units (WU) defined structural CMD (versus functional CMD). Flow and resistance measurements were analysed both in absolute terms and after indexing by subtended mass.

Results: Mass and flow were analysed in 100 patients in the left anterior descending artery. The mean subtended myocardial mass in the structural CMD group (47.00±13.83 grams) was significantly lower than in the control group (59.64±21.69 grams; p=0.027), with no significant difference between the control group and the functional CMD group (53.75±13.99 grams; p=0.339). After indexing by the subtended mass, patients with structural CMD still had higher Rμ,hyper (control: 20.68±7.99 WU•kg vs structural CMD: 30.58±11.63 WU•kg; p<0.001) and lower Qhyper (control: 4.56±2.20 ml/min/g vs structural CMD: 3.20±0.90 ml/min/g; p=0.013). Conversely, patients with functional CMD exhibited similar indexed values of Rμ,hyperand Qhyper to controls.

Conclusions: Despite significantly lower subtended mass, patients with structural CMD exhibit abnormal indexed Rμ,hyper and Qhyper, supporting the notion of hyperaemic flow restriction at the tissue level that is independent of subtended mass. However, patients with functional CMD have similar subtended myocardial mass to controls and exhibit no flow restriction during hyperaemia.

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 16
Aug 18, 2025
Volume 21 Number 16
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV14I5A89 Aug 3, 2018
Microvascular disease, what little we know
Appelman Y
free

Original Research

10.4244/EIJ-D-24-00111 Oct 7, 2024
Absolute coronary blood flow across different endotypes of ANOCA
Paradies V et al

Clinical research

10.4244/EIJ-D-20-00853 Sep 20, 2021
Prognostic impact and clinical outcomes of coronary flow reserve and hyperaemic microvascular resistance
Toya T et al
free
Trending articles
172.65

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
95.95

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
76.3

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
63

Image – Interventional flashlight

10.4244/EIJ-D-22-00074 Jun 3, 2022
Transcatheter aortic valve repair for aortic regurgitation with the Cusper device
Feld Y et al
free
58.2

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
49.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
49.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
31.1

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
30.4

Clinical Research

10.4244/EIJ-D-21-00363 Jan 28, 2022
Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation
Jørgensen T et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved